Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Assembly Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Merger 10
Ventrus Biosciences Completes Merger with Assembly Pharma 10
Licensing Agreements 11
Allergan Enters into Licensing Agreement with Assembly Biosciences 11
Ventrus Biosciences Enters into Licensing Agreement with Therabiome 13
Assembly Biosciences Enters Into Licensing Agreement with Indiana University Research and Technology 14
Assembly Pharma Enters into Licensing Agreement with IURTC 15
Equity Offering 16
Assembly Biosciences Raises USD165.6 Million in Public Offering of Shares 16
Assembly Biosciences Plans to Raise up to USD250 Million in Public Offering of Securities 18
Assembly Biosciences Prices Public Offering of Shares for USD60.2 Million 19
Assembly Biosciences Completes Underwriters Exercise of Over-Allotment of Public Offering of Shares 20
Assembly Biosciences Raises USD15.8 million in Private Placement of Shares 22
Ventrus Biosciences Announces Public Offering Of Shares For US$20.5 Million 23
Ventrus Biosciences Completes Underwriters’ Exercise Of Over-Allotment Option For Public Offering Of Shares For US$16.7 Million 24
Ventrus Biosciences Completes Public Offering Of Preferred Shares For US$5.5 Million 26
Assembly Biosciences Inc – Key Competitors 27
Assembly Biosciences Inc – Key Employees 28
Assembly Biosciences Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 08, 2018: Assembly Biosciences announces second quarter 2018 financial results 30
May 07, 2018: Assembly Biosciences Reports First Quarter 2018 Financial Results 32
Corporate Communications 33
Apr 02, 2018: Assembly Biosciences Appoints Jackie Papkoff, PhD, Senior Vice President, Chief Scientific Officer Microbiome 33
Mar 12, 2018: Assembly Biosciences Announces Additions to Management Team and Board of Directors 34
Dec 18, 2017: Assembly Biosciences Appoints Sue Mahony, PhD to Board of Directors 36
Jul 28, 2017: Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 37
Clinical Trials 38
Sep 25, 2017: Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Assembly Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Assembly Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ventrus Biosciences Completes Merger with Assembly Pharma 10
Allergan Enters into Licensing Agreement with Assembly Biosciences 11
Ventrus Biosciences Enters into Licensing Agreement with Therabiome 13
Assembly Biosciences Enters Into Licensing Agreement with Indiana University Research and Technology 14
Assembly Pharma Enters into Licensing Agreement with IURTC 15
Assembly Biosciences Raises USD165.6 Million in Public Offering of Shares 16
Assembly Biosciences Plans to Raise up to USD250 Million in Public Offering of Securities 18
Assembly Biosciences Prices Public Offering of Shares for USD60.2 Million 19
Assembly Biosciences Completes Underwriters Exercise of Over-Allotment of Public Offering of Shares 20
Assembly Biosciences Raises USD15.8 million in Private Placement of Shares 22
Ventrus Biosciences Announces Public Offering Of Shares For US$20.5 Million 23
Ventrus Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For Public Offering Of Shares For US$16.7 Million 24
Ventrus Biosciences Completes Public Offering Of Preferred Shares For US$5.5 Million 26
Assembly Biosciences Inc, Key Competitors 27
Assembly Biosciences Inc, Key Employees 28
Assembly Biosciences Inc, Other Locations 29
Assembly Biosciences Inc, Subsidiaries 29
List of Figures
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Assembly Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8